艾迪药业
(688488)
| 流通市值：64.55亿 | | | 总市值：64.55亿 |
| 流通股本：4.21亿 | | | 总股本：4.21亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 397,241,391.9 | 503,947,868.77 | 371,162,584.86 | 341,015,417.63 |
| 交易性金融资产 | 90,217,641.51 | 30,114,622.64 | 80,188,356.17 | 80,183,509.95 |
| 应收票据及应收账款 | 176,444,074.01 | 155,944,178.01 | 164,799,252.92 | 172,183,004.27 |
| 其中：应收票据 | 6,186,038.6 | 9,294,040.54 | 13,384,422.73 | 10,320,941.65 |
| 应收账款 | 170,258,035.41 | 146,650,137.47 | 151,414,830.19 | 161,862,062.62 |
| 应收款项融资 | 37,002,076.15 | 43,629,258.79 | 36,105,764.5 | 31,681,021.7 |
| 预付款项 | 6,802,321.79 | 3,760,914.67 | 5,331,098.83 | 7,831,367.62 |
| 其他应收款合计 | 7,262,405.43 | 7,191,704.53 | 13,026,513.2 | 8,343,290.71 |
| 存货 | 272,107,240.66 | 257,919,704.29 | 259,491,737.93 | 245,852,021.48 |
| 其他流动资产 | 14,394,170.9 | 10,191,255.28 | 8,632,678.52 | 8,700,361.94 |
| 流动资产合计 | 1,001,471,322.35 | 1,012,699,506.98 | 938,737,986.93 | 895,789,995.3 |
| 非流动资产: | | | | |
| 长期股权投资 | 2,537,239.5 | 2,825,575.14 | 3,186,368.02 | 461,342.53 |
| 其他非流动金融资产 | 83,593,000 | 88,778,900 | 87,630,800 | 77,718,947.25 |
| 固定资产 | 388,350,883.33 | 391,446,414.68 | 398,945,512.47 | 404,664,453.46 |
| 在建工程 | 644,778.76 | 1,106,098 | - | 1,846,913.09 |
| 使用权资产 | 9,095,790.13 | 9,916,345.96 | 5,314,011.91 | 5,863,423.47 |
| 无形资产 | 148,637,463.53 | 149,713,096.26 | 154,641,454.61 | 159,879,460.23 |
| 开发支出 | 57,033,508.59 | 44,240,037.61 | 35,539,418.03 | 9,558,307.82 |
| 商誉 | 171,616,799.19 | 171,616,799.19 | 171,616,799.19 | 171,616,799.19 |
| 长期待摊费用 | 27,502,564.53 | 28,750,284.11 | 30,286,798.64 | 27,723,489.47 |
| 递延所得税资产 | 81,536,186.41 | 84,645,306.14 | 83,725,108.4 | 86,970,328.89 |
| 其他非流动资产 | 3,004,450.3 | 73,150,562.53 | 2,973,726.5 | 2,849,650 |
| 非流动资产合计 | 973,552,664.27 | 1,046,189,419.62 | 973,859,997.77 | 949,153,115.4 |
| 资产总计 | 1,975,023,986.62 | 2,058,888,926.6 | 1,912,597,984.7 | 1,844,943,110.7 |
| 流动负债: | | | | |
| 短期借款 | 369,030,313.89 | 428,106,087.23 | 365,181,051.95 | 289,004,927.5 |
| 应付票据及应付账款 | 94,349,287.78 | 85,961,168.38 | 92,774,270.93 | 102,788,473.54 |
| 其中：应付票据 | 11,807,647.92 | 18,537,146.42 | 13,652,132.23 | 19,041,003.08 |
| 应付账款 | 82,541,639.86 | 67,424,021.96 | 79,122,138.7 | 83,747,470.46 |
| 合同负债 | 7,009,922.01 | 6,604,622.47 | 5,217,175.06 | 5,732,607.86 |
| 应付职工薪酬 | 17,669,284.71 | 15,861,056.03 | 24,726,315.45 | 16,855,134.46 |
| 应交税费 | 11,572,689.89 | 8,444,629.31 | 19,786,342.39 | 14,035,543.92 |
| 其他应付款合计 | 61,933,890.81 | 70,322,143.84 | 73,449,452.38 | 73,727,002.32 |
| 一年内到期的非流动负债 | 46,799,213.44 | 52,913,425.12 | 118,568,050.65 | 119,737,006.26 |
| 其他流动负债 | 7,684,811.21 | 7,471,206.06 | 9,506,964.76 | 10,037,959.76 |
| 流动负债合计 | 616,049,413.74 | 675,684,338.44 | 709,209,623.57 | 631,918,655.62 |
| 非流动负债: | | | | |
| 长期借款 | 325,246,000 | 231,238,000 | 71,736,000 | 71,736,000 |
| 租赁负债 | 7,236,594.91 | 7,658,338.52 | 3,666,938.19 | 4,071,764.02 |
| 递延收益 | 41,573,511.27 | 42,957,344.35 | 43,761,846.4 | 45,542,312.8 |
| 递延所得税负债 | 10,547,286.11 | 11,721,517.26 | 10,996,348.87 | 9,698,108.5 |
| 非流动负债合计 | 384,603,392.29 | 293,575,200.13 | 130,161,133.46 | 131,048,185.32 |
| 负债合计 | 1,000,652,806.03 | 969,259,538.57 | 839,370,757.03 | 762,966,840.94 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 420,782,808 | 420,782,808 | 420,782,808 | 420,782,808 |
| 资本公积 | 814,232,447.61 | 889,564,881.57 | 887,329,323.03 | 887,921,695.71 |
| 其他综合收益 | 549,789.4 | 549,789.4 | 549,789.4 | 549,789.4 |
| 专项储备 | 1,205,901.32 | 885,226.74 | 896,766.25 | 962,139.83 |
| 盈余公积 | 9,307,578.93 | 9,307,578.93 | 9,307,578.93 | 9,307,578.93 |
| 未分配利润 | -331,252,813.07 | -346,580,633.62 | -354,186,886.73 | -341,495,080.91 |
| 归属于母公司股东权益合计 | 914,825,712.19 | 974,509,651.02 | 964,679,378.88 | 978,028,930.96 |
| 少数股东权益 | 59,545,468.4 | 115,119,737.01 | 108,547,848.79 | 103,947,338.8 |
| 股东权益合计 | 974,371,180.59 | 1,089,629,388.03 | 1,073,227,227.67 | 1,081,976,269.76 |
| 负债和股东权益合计 | 1,975,023,986.62 | 2,058,888,926.6 | 1,912,597,984.7 | 1,844,943,110.7 |
| 公告日期 | 2026-08-29 | 2026-04-30 | 2026-03-31 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |